low glutathione levels parkinson's disease Treatment Targeting the Cysteine Redox Proteome
Description
Spencer, N
doi: 10.3389/fmicb.2020.589726 Received 31 July 2020 Accepted 23 November 2020 Published 15 December 2020 Volume 11 - 2020 Edited by Zongxin Ling, Zhejiang University, China Reviewed by Guillaume Sarrabayrouse, Vall dHebron Research Institute (VHIR), Spain
Epigenetic modifications influence the energy metabolism processes of T2DM patients
The therapeutic role of exercise training during menopause for reducing vascular disease
